Michael R. Bristow - Pres. & Chief Executive Offic, Director at Oruka Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Executive Offic, Director
Issuer Symbol
ORKA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael R. Bristow since 13 Mar 2025

Holdings reported by Michael R. Bristow for Oruka Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,285 $5,713 $2.50 14 Dec 2021 Direct
Common Stock 1,414 $3,535 $2.50 14 Dec 2021 By NFS Custodian for Michael Bristow's IRA
Common Stock 1,109 $2,773 $2.50 14 Dec 2021 By InvestocorTrust as sole Trustee
Stock Option (right to buy) 95,000 14 Dec 2021 Direct Common Stock

Transactions reported by Michael R. Bristow for Oruka Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.